
Blueprint Medicines Corporation BPMC
Quartalsbericht 2025-Q1
hinzugefügt 01.05.2025
Blueprint Medicines Corporation ROCE 2011-2026 | BPMC
ROCE Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -60.1 | -51.49 | -22.48 | -28.54 | -32.23 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -22.48 | -60.1 | -38.97 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | ||
|
Aeterna Zentaris
AEZS
|
-29.95 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-49.48 | - | 2.54 % | $ 160 B | ||
|
Aileron Therapeutics
ALRN
|
-119.71 | - | 10.36 % | $ 9.8 M | ||
|
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M | ||
|
Ascendis Pharma A/S
ASND
|
-45.89 | $ 217.43 | -0.29 % | $ 5 B | ||
|
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
17.8 | $ 19.34 | 0.57 % | $ 904 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-57.84 | $ 8.35 | -0.95 % | $ 111 M | ||
|
CytomX Therapeutics
CTMX
|
-22.59 | $ 4.28 | -4.15 % | $ 590 M | ||
|
AgeX Therapeutics
AGE
|
-180.78 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
Eton Pharmaceuticals
ETON
|
-3.23 | $ 23.25 | -2.35 % | $ 626 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
-109.6 | $ 0.68 | 12.19 % | $ 7.79 M | ||
|
Adverum Biotechnologies
ADVM
|
-196.79 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | ||
|
Exelixis
EXEL
|
40.35 | $ 41.76 | 0.85 % | $ 11.3 B | ||
|
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-161.2 | $ 1.34 | -4.29 % | $ 342 M | ||
|
Fulcrum Therapeutics
FULC
|
-24.29 | $ 6.71 | -2.61 % | $ 425 K | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
ChemoCentryx
CCXI
|
-45.41 | - | - | $ 3.74 B | ||
|
Genmab A/S
GMAB
|
31.74 | $ 25.83 | 0.56 % | $ 16.6 B | ||
|
Aytu BioScience
AYTU
|
-12.81 | $ 2.6 | -1.14 % | $ 16.3 M | ||
|
Grifols, S.A.
GRFS
|
7.15 | $ 7.6 | -1.24 % | $ 6.83 B | ||
|
Halozyme Therapeutics
HALO
|
960.8 | $ 62.18 | -1.08 % | $ 7.45 B | ||
|
Atreca
BCEL
|
-34.9 | - | -11.76 % | $ 5.79 M | ||
|
BioDelivery Sciences International
BDSI
|
19.77 | - | -4.8 % | $ 255 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | ||
|
BeiGene, Ltd.
BGNE
|
7.03 | - | 0.49 % | $ 251 B | ||
|
Immatics N.V.
IMTX
|
1.74 | $ 9.3 | -2.21 % | $ 585 M | ||
|
Incyte Corporation
INCY
|
29.32 | $ 90.43 | -0.02 % | $ 17.7 B | ||
|
Bellerophon Therapeutics
BLPH
|
-883.35 | - | -74.18 % | $ 955 K | ||
|
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-49.83 | $ 4.38 | -1.02 % | $ 839 M | ||
|
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | ||
|
Ionis Pharmaceuticals
IONS
|
-43.85 | $ 69.92 | -1.23 % | $ 11.2 B | ||
|
AIkido Pharma
AIKI
|
-28.92 | - | 1.93 % | $ 17.4 M | ||
|
Allakos
ALLK
|
-116.14 | - | - | $ 28.6 M | ||
|
Brickell Biotech
BBI
|
-64.05 | - | -5.38 % | $ 6.06 M |